Martin Walton

Martin was appointed to the Board in March 2022.

Martin spent 25 years in global investment banking and asset management, culminating as Vice Chair in charge of Wholesale and Commercial Banking for Europe and Asia-Pacific at Toronto Dominion Bank.

Since 2010, Martin has been an active VC / PE investor, portfolio manager, and advisor in life sciences involving a number of Executive and non-Executive positions, completing over 25 transactions (spinouts, financings, M&A, IPOs, divestitures) and has raised over £1bn in investment and co-investment capital.

Martin is co-founder of LSE-listed Arix Bioscience plc (LSE: ARIX) and currently serves as Chairman and CEO of Bradshaw Consulting Ltd. He is CEO of virtual biotech Excalibur Medicines Ltd, Board Director of Interrad Medical, and a Board Member of the Liverpool Life Sciences Accelerator Partnership.